HYPOPITUARISM

The pituitary gland produces a number of hormones or chemicals which are released into the blood to control other glands in the body. If the pituitary is not producing one or more of these hormones, or not producing enough, then this condition is known as hypopituitarism. If all the hormones produced by the pituitary are affected this condition is known as panhypopituitarism.

Hypopituitarism is most often caused by a benign (i.e. not cancerous) tumour of the pituitary gland, or of the brain in the region of the hypothalamus. Pituitary underactivity may be caused by the direct pressure of the tumour mass on the normal pituitary or by the effects of surgery or radiotherapy used to treat the tumour. Less frequently, hypopituitarism can be caused by infections (such as meningitis) in or around the brain or by severe blood loss, by head injury, or by various rare diseases such as sarcoidosis.

Typical symptoms

• excessive tiredness and decreased energy
• muscle weakness
• reduced body hair
• irregular periods (oligomenorrhoea) or loss of normal menstrual function (amenorrhoea) – females
• impotence – males
• reduced fertility
• decrease in sex drive
• weight gain
• increased sensitivity to cold
• constipation
• dry skin
• pale appearance
• low blood pressure and dizziness on standing (postural hypotension)
• headaches
• vision disturbance
• Diabetes Insipidus

Each of the symptoms described above occur in response to the loss of one or more of the hormones produced by the pituitary.

Disclaimer
All information given is general. If you or your carer have any concern about your treatment or any side effects please read the Patient Information leaflet enclosed with your medication or consult your GP or endocrinologist.
This information has been given with kind permission from The Pituitary Foundation ©
This material may not be reproduced in any form nor by any means without the permission of The Pituitary Foundation.

WAPO Contacts

WAPO believes that the strength of a global network of national pituitary patient organizations will lead to improved diagnosis, treatment and care for pituitary and adrenal patients worldwide.